Chordia Therapeutics Inc.
Chordia Therapeutics Inc. scores highest on Torque (50) and lowest on Nitro (7). Its PosiPenta is 23.11 out of 100, weaker than most similar companies.
On the Penta Grid this week, Chordia Therapeutics Inc. is Grid #79 of 91 in the Healthcare sector in Japan, and Grid #1,309 of 1,383 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Chordia Therapeutics Inc. | 23.11 | 23 | 18 | 7 | 50 | 17 |
| Noile-Immune Biotech Inc. | 30.82 | 36 | 12 | 9 | 55 | 41 |
| SymBio Pharmaceuticals Limited | 14.10 | 0 | 43 | 2 | 6 | 20 |
| Kohjin Bio Co., Ltd. | 34.55 | 54 | 39 | 9 | 36 | 36 |
| Japan Hospice Holdings Inc. | 44.69 | 72 | 68 | 5 | 32 | 47 |
| D. Western Therapeutics Institute, Inc. | 22.95 | 14 | 22 | 17 | 24 | 39 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.58 |
| P/B ratio | 1.64 |
EEarnings
| Trailing EPS | ₹-11.93 |
| Forward EPS | — |
NNitro
| Price | 30.81 |
| 52-week high | 108.15 |
| 52-week low | 28.40 |
| Fall from 52-week high | 71.5% |
TTorque
| Return on equity (ROE) | -66.71% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 3.07 |
| Market cap | ₹231 Cr |
| Insider holding | 28.21% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Chordia Therapeutics Inc.'s PosiPenta score?
Chordia Therapeutics Inc.'s PosiPenta is 23.11 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does Chordia Therapeutics Inc. stand on the Penta Grid?
On the Penta Grid this week, Chordia Therapeutics Inc. is Grid #79 of 91 in the Healthcare sector in Japan, and Grid #1,309 of 1,383 in Japan.
Which PosiPenta pillar is strongest for Chordia Therapeutics Inc.?
Torque (durability), with a score of 50 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Chordia Therapeutics Inc.?
Nitro (momentum), with a score of 7 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.